{"id":"NCT01307033","sponsor":"Organon and Co","briefTitle":"A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351)","officialTitle":"A Phase III, Randomized, Active-comparator Controlled and a Long-term Clinical Trial to Study the Safety of MK-0954A (L100/H12.5 mg) in Japanese Patients With Essential Hypertension Uncontrolled With MK-954H (L50/H12.5 mg) [PREMINENT®]","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-03-29","primaryCompletion":"2012-12-04","completion":"2012-12-04","firstPosted":"2011-03-02","resultsPosted":"2014-01-06","lastUpdate":"2024-05-17"},"enrollment":278,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Hypertension"],"interventions":[{"type":"DRUG","name":"MK-0954A","otherNames":[]},{"type":"DRUG","name":"MK-954H","otherNames":["Preminent®"]},{"type":"DRUG","name":"Placebo to MK-0954A","otherNames":[]},{"type":"DRUG","name":"Placebo to MK-954H","otherNames":[]}],"arms":[{"label":"MK-954H (L50/H12.5)","type":"ACTIVE_COMPARATOR"},{"label":"MK-0954A (L100/H12.5)","type":"EXPERIMENTAL"}],"summary":"This study is being conducted to evaluate the safety of MK-0954A (L100/H12.5 mg) in essential hypertension participants who are uncontrolled with MK-954H (L50/H12.5 mg).","primaryOutcome":{"measure":"Percentage of Participants Who Experienced an Adverse Event When Receiving MK-0954A (L100/H12.5) During Study (8-week Double-blind and/or 44-week Open-label Extension)","timeFrame":"Up to 52 weeks","effectByArm":[{"arm":"L50/H12.5→L100/H12.5 Open Label (Period 2)","deltaMin":71,"sd":null},{"arm":"L100/H12.5→L100/H12.5 Open Label (Period 2)","deltaMin":72.4,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["24990091"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":144},"commonTop":["Nasopharyngitis","Blood uric acid increased","Upper respiratory tract infection","Upper respiratory tract inflammation","Diabetes mellitus"]}}